Noida, UP -- (SBWire) -- 12/26/2010 -- As per our new research report “Global Protein Therapeutics Market Analysis”, the global Hepatitis C Treatment market exhibits a high growth potential market with promising growth prospects inherent for the industry. With the launch of new protease inhibitors and improved market penetration each year coupled with huge investments by the market players, it is forecasted that the market will grow at a CAGR of around 8% during 2011-2013. Other factors that will contribute to the prospective sales are improvements in therapies, increased awareness, and improved diagnosis rates.
Besides, we have identified some critical factors acting as catalysts for the industry’s current and future growth outlook. The report reveals that increase in the health insurance industry will drive renewed interests of the investors in the therapeutics market at the global level. Moreover, higher prevalence of lifestyle and chronic diseases such as, diabetes, cancer, arthritis etc.
will pave the growth of the market in coming years. Based on some concrete market fundamentals, we anticipate that the global protein therapeutics industry will witness consolidation in coming years globally during our forecast period and will become one of the most dominating market segments of the healthcare industry.
Our report systematically studies the global protein therapeutics market to provide an insight into its various segments, including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor, and Follicle Stimulating Hormone. According to our report, monoclonal antibodies are the current highest share-holder, but future will see insulin segment posting a rapid growth.
“Global Protein Therapeutics Market Analysis” provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing in the regional protein therapeutics market segments across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been thoroughly studied in the report to provide a comprehensive view of the global protein therapeutics market.
The report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
Global Hepatitis C Treatment Market to Grow at 8% CAGR by 2013
With the launch of new protease inhibitors and improved market penetration, the global Hepatitis C Treatment market is anticipated to grow at a CAGR of 8% during 2011-2013, says RNCOS in its latest research study.